"10.1371_journal.pone.0096481","plos one","2014-05-05T00:00:00Z","Tetsuo Kida; Seiko Kozai; Hiroaki Takahashi; Mitsuyoshi Isaka; Hideki Tokushige; Taiji Sakamoto","Research Laboratories for Drug Development, Senju Pharmaceutical Co., Ltd., Kobe, Japan; Department of Ophthalmology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan","Conceived and designed the experiments: TK SK H. Takahashi MI H. Tokushige TS. Performed the experiments: TK SK H. Takahashi. Analyzed the data: TK SK H. Takahashi. Contributed reagents/materials/analysis tools: MI H. Tokushige. Wrote the paper: TK SK H. Tokushige TS.","The authors have the following interests. TK, SK, H. Takahashi, MI, and H. Tokushige are employees of Senju Pharmaceutical Co., Ltd., the funder of this study and the manufacturer, distributor, and licensor of bromfenac ophthalmic solution. Sodium bromfenac was provided by Senju Pharmaceutical Co., Ltd for this study. TK has been a patent pending for the adjunctive use of ophthalmic NSAIDs (Appl. Name: Ophthalmic NSAIDs as Adjuvants, Appl. No. US 12/867,470, PCT No. PCT/US2009/034511) although the patent does not include the data reported in this article. There are no further patents, products in development, or marketed products to declare. TS has declared that no competing interests exit. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2014","05","Tetsuo Kida","TK",6,FALSE,3,3,3,3,TRUE,TRUE,TRUE,1,"6",TRUE
